Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 4 records, 1 pages
Search For: Antidiabetic Glucagon-like Peptide 1 Agonists
Global Antidiabetic Glucagon-like Peptide 1 Agonists Supply, Demand and Key Producers, 2024-2030
24 Feb 2024
Pharma & Healthcare
Antidiabetic Glucagon-like Peptide 1 Agonists
The global Antidiabetic Glucagon-like Peptide 1 Agonists market size is expected to reach $ 7350.8 million by 2030, rising at a market growth of 4.1% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Antidiabetic Glucagon-like Peptide 1 Agonists Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
05 Jan 2024
Pharma & Healthcare
Antidiabetic Glucagon-like Peptide 1 Agonists
According to our (Global Info Research) latest study, the global Antidiabetic Glucagon-like Peptide 1 Agonists market size was valued at USD 5543 million in 2023 and is forecast to a readjusted size of USD 7350.8 million by 2030 with a CAGR of 4.1% during review period.
USD3480.00
Add To Cart
Global Antidiabetic Glucagon-like Peptide 1 Agonists Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
06 Feb 2023
Pharma & Healthcare
Antidiabetic Glucagon-like Peptide 1 Agonists
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
USD3480.00
Add To Cart
Global Antidiabetic Glucagon-like Peptide 1 Agonists Supply, Demand and Key Producers, 2023-2029
03 Feb 2023
Pharma & Healthcare
Antidiabetic Glucagon-like Peptide 1 Agonists
The global Antidiabetic Glucagon-like Peptide 1 Agonists market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Antidiabetic Glucagon-like Peptide 1 Agonists
Total: 4 records, 1 pages
The global Antidiabetic Glucagon-like Peptide 1 Agonists market size is expected to reach $ 7350.8 million by 2030, rising at a market growth of 4.1% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Antidiabetic Glucagon-like Peptide 1 Agonists market size was valued at USD 5543 million in 2023 and is forecast to a readjusted size of USD 7350.8 million by 2030 with a CAGR of 4.1% during review period.
USD3480.00
Add To Cart
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
USD3480.00
Add To Cart
The global Antidiabetic Glucagon-like Peptide 1 Agonists market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>